Global ALK Positive Lung Cancer Treatment Market Research Report 2023

Report ID: 1878573 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Crizotinib
        1.2.3 Alectinib
        1.2.4 Ceritinib
        1.2.5 Brigatinib
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global ALK Positive Lung Cancer Treatment Market Perspective (2017-2028)
    2.2 ALK Positive Lung Cancer Treatment Growth Trends by Region
        2.2.1 ALK Positive Lung Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 ALK Positive Lung Cancer Treatment Historic Market Size by Region (2017-2022)
        2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2023-2028)
    2.3 ALK Positive Lung Cancer Treatment Market Dynamics
        2.3.1 ALK Positive Lung Cancer Treatment Industry Trends
        2.3.2 ALK Positive Lung Cancer Treatment Market Drivers
        2.3.3 ALK Positive Lung Cancer Treatment Market Challenges
        2.3.4 ALK Positive Lung Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue
        3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2017-2022)
        3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
    3.4 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
        3.4.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2021
    3.5 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
    3.7 Date of Enter into ALK Positive Lung Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 ALK Positive Lung Cancer Treatment Breakdown Data by Type
    4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2017-2022)
    4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 ALK Positive Lung Cancer Treatment Breakdown Data by Application
    5.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Application (2017-2022)
    5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America ALK Positive Lung Cancer Treatment Market Size (2017-2028)
    6.2 North America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
    6.3 North America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2017-2028)
    7.2 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
    7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size (2017-2028)
    8.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America ALK Positive Lung Cancer Treatment Market Size (2017-2028)
    9.2 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
    9.3 Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size (2017-2028)
    10.2 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 F. Hoffmann-La Roche
        11.1.1 F. Hoffmann-La Roche Company Detail
        11.1.2 F. Hoffmann-La Roche Business Overview
        11.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
        11.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.1.5 F. Hoffmann-La Roche Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
        11.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
        11.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.3.5 Novartis Recent Development
    11.4 TP Therapeutics
        11.4.1 TP Therapeutics Company Detail
        11.4.2 TP Therapeutics Business Overview
        11.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
        11.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.4.5 TP Therapeutics Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Detail
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
        11.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Eli Lilly and Company
        11.6.1 Eli Lilly and Company Company Detail
        11.6.2 Eli Lilly and Company Business Overview
        11.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
        11.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.6.5 Eli Lilly and Company Recent Development
    11.7 Takeda
        11.7.1 Takeda Company Detail
        11.7.2 Takeda Business Overview
        11.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
        11.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.7.5 Takeda Recent Development
    11.8 Beacon Pharma
        11.8.1 Beacon Pharma Company Detail
        11.8.2 Beacon Pharma Business Overview
        11.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
        11.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
        11.8.5 Beacon Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Crizotinib
    Table 3. Key Players of Alectinib
    Table 4. Key Players of Ceritinib
    Table 5. Key Players of Brigatinib
    Table 6. Key Players of Other
    Table 7. Global ALK Positive Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global ALK Positive Lung Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global ALK Positive Lung Cancer Treatment Market Share by Region (2017-2022)
    Table 11. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global ALK Positive Lung Cancer Treatment Market Share by Region (2023-2028)
    Table 13. ALK Positive Lung Cancer Treatment Market Trends
    Table 14. ALK Positive Lung Cancer Treatment Market Drivers
    Table 15. ALK Positive Lung Cancer Treatment Market Challenges
    Table 16. ALK Positive Lung Cancer Treatment Market Restraints
    Table 17. Global ALK Positive Lung Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global ALK Positive Lung Cancer Treatment Market Share by Players (2017-2022)
    Table 19. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2021)
    Table 20. Ranking of Global Top ALK Positive Lung Cancer Treatment Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by ALK Positive Lung Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
    Table 24. Date of Enter into ALK Positive Lung Cancer Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global ALK Positive Lung Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2017-2022)
    Table 28. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2023-2028)
    Table 30. Global ALK Positive Lung Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2017-2022)
    Table 32. Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global ALK Positive Lung Cancer Treatment Revenue Market Share by Application (2023-2028)
    Table 34. North America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. F. Hoffmann-La Roche Company Detail
    Table 45. F. Hoffmann-La Roche Business Overview
    Table 46. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
    Table 47. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 48. F. Hoffmann-La Roche Recent Development
    Table 49. Pfizer Company Detail
    Table 50. Pfizer Business Overview
    Table 51. Pfizer ALK Positive Lung Cancer Treatment Product
    Table 52. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 53. Pfizer Recent Development
    Table 54. Novartis Company Detail
    Table 55. Novartis Business Overview
    Table 56. Novartis ALK Positive Lung Cancer Treatment Product
    Table 57. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 58. Novartis Recent Development
    Table 59. TP Therapeutics Company Detail
    Table 60. TP Therapeutics Business Overview
    Table 61. TP Therapeutics ALK Positive Lung Cancer Treatment Product
    Table 62. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 63. TP Therapeutics Recent Development
    Table 64. Bristol-Myers Squibb Company Detail
    Table 65. Bristol-Myers Squibb Business Overview
    Table 66. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
    Table 67. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 68. Bristol-Myers Squibb Recent Development
    Table 69. Eli Lilly and Company Company Detail
    Table 70. Eli Lilly and Company Business Overview
    Table 71. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
    Table 72. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 73. Eli Lilly and Company Recent Development
    Table 74. Takeda Company Detail
    Table 75. Takeda Business Overview
    Table 76. Takeda ALK Positive Lung Cancer Treatment Product
    Table 77. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 78. Takeda Recent Development
    Table 79. Beacon Pharma Company Detail
    Table 80. Beacon Pharma Business Overview
    Table 81. Beacon Pharma ALK Positive Lung Cancer Treatment Product
    Table 82. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 83. Beacon Pharma Recent Development
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global ALK Positive Lung Cancer Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Crizotinib Features
    Figure 3. Alectinib Features
    Figure 4. Ceritinib Features
    Figure 5. Brigatinib Features
    Figure 6. Other Features
    Figure 7. Global ALK Positive Lung Cancer Treatment Market Share by Application in 2021 & 2028
    Figure 8. Hospital Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Other Case Studies
    Figure 11. ALK Positive Lung Cancer Treatment Report Years Considered
    Figure 12. Global ALK Positive Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global ALK Positive Lung Cancer Treatment Market Share by Region: 2021 VS 2028
    Figure 15. Global ALK Positive Lung Cancer Treatment Market Share by Players in 2021
    Figure 16. Global Top ALK Positive Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by ALK Positive Lung Cancer Treatment Revenue in 2021
    Figure 18. North America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America ALK Positive Lung Cancer Treatment Market Share by Country (2017-2028)
    Figure 20. United States ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe ALK Positive Lung Cancer Treatment Market Share by Country (2017-2028)
    Figure 24. Germany ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific ALK Positive Lung Cancer Treatment Market Share by Region (2017-2028)
    Figure 32. China ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America ALK Positive Lung Cancer Treatment Market Share by Country (2017-2028)
    Figure 40. Mexico ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa ALK Positive Lung Cancer Treatment Market Share by Country (2017-2028)
    Figure 44. Turkey ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 47. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 48. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 49. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 50. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 51. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 52. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 53. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F. Hoffmann-La Roche
Pfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
Frequently Asked Questions
ALK Positive Lung Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
ALK Positive Lung Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
ALK Positive Lung Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Alkyl Acetates

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Alkyl Acrylate

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More